Hypha Labs, Inc.
FUNI
$0.03
$0.0017.44%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -63.61% | -3.94% | -12.65% | 7.87% | 1,748.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -63.61% | -3.94% | -12.65% | 7.87% | 1,748.87% |
| Operating Income | 63.61% | 3.94% | 12.65% | -7.87% | -1,748.87% |
| Income Before Tax | 61.06% | -16.87% | 22.97% | -7,922.50% | -850.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 61.06% | -19.83% | 20.50% | -1,031.92% | -850.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.06% | -19.83% | 20.50% | -372.18% | -983.64% |
| EBIT | 63.61% | 3.94% | 12.65% | -7.87% | -1,748.87% |
| EBITDA | 63.72% | 4.42% | 13.33% | -- | -- |
| EPS Basic | 68.52% | 2.56% | 37.88% | -288.46% | -735.29% |
| Normalized Basic EPS | 68.18% | 14.81% | 29.73% | 29.55% | -560.00% |
| EPS Diluted | 68.52% | 2.56% | 59.00% | -484.62% | -735.29% |
| Normalized Diluted EPS | 68.18% | 14.81% | 29.73% | 29.55% | -560.00% |
| Average Basic Shares Outstanding | 21.74% | 24.92% | 27.12% | 42.35% | 43.08% |
| Average Diluted Shares Outstanding | 21.74% | 24.92% | 27.12% | 42.35% | 43.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |